P - Cautioned in pregnancy
L - Cautioned in lactation
Artemether (INN) is an antimalarial for the treatment of multi-drug resistant strains of falciparum malaria. It is combined with Lumefantrine and sold by Novartis under the brand names Riamet and Co-Artem.
It is an ether derivative of artemisinin.
Special Populations
Renal Function Impairment
No specific pharmacokinetic studies have been performed.
Hepatic Function Impairment
No specific pharmacokinetic studies have been performed.
Elderly
No specific pharmacokinetic studies have been performed in patients older than 65 years of age.
Children
Systemic exposure is comparable with adult patients.
Gender
No clinically relevant effects.
In acute uncomplicated falciparum malaria
Mild GI disturbance, dizziness, tinnitus, reduction in reticulocyte and leucocyte counts, nausea, vomiting, abdominal pain, bradycardia, 1st-degree heart block, transient increase in serum transaminases.
Information Not Available
Pregnancy and lactation. Avoid concomitant use of drugs known to prolong QT interval or monitor such patients.
Artemether causes QT prolongation in some patients. Thus concomitant use of erythromycin, terfenadine, procainamide, quinidine, disopyramide, amiodarone, bretylium, bepridil, sotalol, astemizole, probucol, tricyclic antidepressants, phenothiazines may be avoided.
Information Not Available
Oral
Acute uncomplicated falciparum malaria
Adult: 80 mg daily, to be taken with lumefantrine 480 mg daily. Doses to be taken at diagnosis and repeated after 8, 24, 36, 48 and 60 hr. Total doses: 6.
Child: Daily doses based on body wt: 5-14 kg: 20 mg with lumefantrine 120 mg; 15-24 kg: 40 mg with lumefantrine 240 mg; 25-34 kg: 60 mg with lumefantrine 360 mg and >34 kg: 80 mg with lumefantrine 480 mg. Doses to be taken at diagnosis and repeated after 8, 24, 36, 48 and 60 hr. Total doses: 6.
Should be taken with food
Caution when used during pregnancy
Caution when used during lactation
Information Not Available
Information Not Available
Hypersensitivity
Oral: Store below 30°C
Oral: Store below 30°C
You will hear from us only if the bid amount matches the minimum threshold and intended usage match our vision. You can resubmit another bid.